SOCS3 and Optic Nerve Regeneration in Zebrafish
About the Research Project
Program
Award Type
Standard
Award Amount
$90,000
Active Dates
April 01, 2006 - March 31, 2008
Grant ID
G2006025
Acknowledgement
Summary
Glaucoma often leads to blindness due to optic nerve damage and retinal ganglion cell death. Optic nerve regeneration may restore vision in patients suffering from glaucoma. Unfortunately the damaged mammalian optic nerve does not readily regenerate. Interestingly, fish regenerate their optic nerve following damage and therefore provide an ideal system for studying the mechanisms underlying successful optic nerve regeneration. In a recent screen for genes that might mediate successful optic nerve regeneration in zebrafish, Dr. Goldman has identified suppressor of cytokine signaling 3 (SOCS3), which is highly induced in retinal ganglion cells that are regenerating their optic axons. SOCS3 is a multifunctional SOCS protein that not only modulates the immune response, but can also influence a number of signal transduction cascades that impact cell survival and axon outgrowth. In this grant application he proposes to test whether SOCS3 is essential for successful optic nerve regeneration. This will be accomplished by knocking down the expression of SOCS3 in adult retinal ganglion cells whose optic axons have been lesioned and assaying cell survival and optic axon regeneration in vivo.
Related Grants
National Glaucoma Research
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
National Glaucoma Research
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute